HEALTH● LOWAug 20 · Aug 20, 2026, 12:27 PM
AC Immune gains on early-stage trial data for anti-inflammatory agent
Seeking Alpha Tech
AC Immune's stock gained following the release of early-stage trial data for its anti-inflammatory agent. This news reflects progress in pharmaceutical development and its market impact.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH32m agoBiohaven surges as FDA accepts resubmission for Vyglxia for spinocerebellar ataxiaSeeking Alpha TechHEALTH43m agoEbola: Africa CDC urges African ownership, accountability in outbreak responsePremium TimesHEALTH43m agoScrewworm spreads to US wildlife in Texas, USDA saysThe HillHEALTH45m agoFirst known human case of Shamonda virus confirmed in FrancePolitico Europe